Atropine Sulfate Injection shortage
Current 19 presentations · 8 manufacturers · first FDA posting Jan 1, 2012 · last update Oct 15, 2026
Manufacturers: Accord Healthcare Inc., American Regent, Inc., Amphastar Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Medefil, Inc., Somerset Therapeutics, LLC
Stated reasons (per FDA): Discontinuation of the manufacture of the drug; Other; Requirements related to complying with good manufacturing practices
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Accord Healthcare Inc. | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted Jan 1, 2020 Updated Oct 3, 2026 |
| Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Accord Healthcare Inc. | Current Available |
— | Posted Jan 1, 2020 Updated Oct 3, 2026 | |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Accord Healthcare Inc. | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted Jan 1, 2020 Updated Oct 3, 2026 |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Accord Healthcare Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: TBD | Posted Jan 1, 2012 Updated Oct 3, 2026 |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Accord Healthcare Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: mid-September 2026 | Posted Jan 1, 2012 Updated Sep 1, 2026 |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Accord Healthcare Inc. | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: late December 2026/early January 2027 | Posted Jan 1, 2012 Updated Oct 3, 2026 |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | American Regent, Inc. | Current Available |
— | Posted Jan 1, 2012 Updated Oct 15, 2026 | |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | American Regent, Inc. | Current Available |
— | Posted Jan 1, 2012 Updated Oct 15, 2026 | |
| Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Amphastar Pharmaceuticals, Inc. | Current Available |
— | Posted Jan 1, 2020 Updated Oct 5, 2026 | |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Next release October 2026. Check wholesalers for inventory. | Posted Jan 1, 2012 Updated Oct 15, 2026 |
| Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted Dec 20, 2023 Updated Oct 14, 2026 | |
| Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay | Posted Jan 1, 2012 Updated Oct 8, 2026 |
| Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Jan 1, 2012 Updated Oct 8, 2026 | |
| Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Medefil, Inc. | Current Available |
— | Posted Jan 1, 2012 Updated Oct 15, 2026 | |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) | Somerset Therapeutics, LLC | Current Available |
— | Posted Jan 1, 2012 Updated Sep 11, 2026 | |
| Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted Jan 1, 2012 Updated Sep 11, 2026 | |
| Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted Jan 1, 2012 Updated Sep 11, 2026 | |
| Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Nov 7, 2025 Updated Nov 7, 2025 Discontinued Nov 7, 2025 |
| Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Nov 7, 2025 Updated Nov 7, 2025 Discontinued Nov 7, 2025 |